Nutriflex Omega 56/144/40 elektrolytfri Infusionsvätska, emulsion

국가: 스웨덴

언어: 스웨덴어

출처: Läkemedelsverket (Medical Products Agency)

환자 정보 전단 환자 정보 전단 (PIL)
15-11-2017
제품 특성 요약 제품 특성 요약 (SPC)
02-01-2024

유효 성분:

alanin; arginin; asparaginsyra; fenylalanin; glukosmonohydrat; glutaminsyra; glycin; histidin; isoleucin; leucin; lysinmonohydrat; metionin; omega-3-syratriglycerider; prolin; serin; sojaolja, raffinerad; treonin; triglycerider, medellångkedjiga; tryptofan; valin

제공처:

B. Braun Melsungen AG

ATC 코드:

B05BA10

INN (International Name):

alanine; arginine; aspartic acid; phenylalanine; glukosmonohydrat; glutamic acid; glycine; histidine; isoleucine; leucine; lysinmonohydrat; methionine; omega-3 fatty acids-syratriglycerider; proline; serine; soybean oil, refined; threonine; triglycerides, medellångkedjiga; tryptophan; valine

약제 형태:

Infusionsvätska, emulsion

구성:

glutaminsyra 12,27 mg Aktiv substans; asparaginsyra 5,25 mg Aktiv substans; histidin 4,38 mg Aktiv substans; prolin 11,9 mg Aktiv substans; arginin 9,45 mg Aktiv substans; isoleucin 8,21 mg Aktiv substans; tryptofan 2 mg Aktiv substans; glukosmonohydrat 396 mg Aktiv substans; omega-3-syratriglycerider 20 mg Aktiv substans; sojaolja, raffinerad 80 mg Aktiv substans; triglycerider, medellångkedjiga 100 mg Aktiv substans; glycerol Hjälpämne; lysinmonohydrat 8,94 mg Aktiv substans; metionin 6,84 mg Aktiv substans; glycin 5,78 mg Aktiv substans; alanin 16,98 mg Aktiv substans; serin 10,5 mg Aktiv substans; leucin 10,96 mg Aktiv substans; fenylalanin 12,29 mg Aktiv substans; valin 9,01 mg Aktiv substans; treonin 6,35 mg Aktiv substans

처방전 유형:

Receptbelagt

제품 요약:

Förpacknings: Trekammarpåse, 5 x 625 ml; Trekammarpåse, 5 x 1875 ml; Trekammarpåse, 5 x 1250 ml

승인 상태:

Godkänd

승인 날짜:

2016-12-09

환자 정보 전단

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
NUTRIFLEX OMEGA SPECIAL ELEKTROLYTFRI
EMULSION FOR INFUSION
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
●
Keep this leaflet. You may need to read it again.
●
If you have any further questions, ask your doctor, pharmacist or
nurse.
●
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.
●
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Nutriflex Omega special elektrolytfri is and what it is used for
2.
What you need to know before you use Nutriflex Omega special
elektrolytfri
3.
How to use Nutriflex Omega special elektrolytfri
4.
Possible side effects
5.
How to store Nutriflex Omega special elektrolytfri
6.
Contents of the pack and other information
1.
WHAT NUTRIFLEX OMEGA SPECIAL ELEKTROLYTFRI IS AND WHAT IT IS USED FOR
Nutriflex Omega special elektrolytfri contains fluids and substances
called amino acids and fatty acids that are
essential for the body to grow or to recover. It also contains
calories in the form of carbohydrates and fats.
Nutriflex Omega special elektrolytfri is given to adults.
You are given Nutriflex Omega special elektrolytfri when you are
unable to eat food normally. There are many
situations when this might be the case, for example when you are
recovering from surgery, injuries, or burns, or
when you are unable to absorb food from your stomach and gut.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE NUTRIFLEX OMEGA SPECIAL
ELEKTROLYTFRI
DO NOT USE NUTRIFLEX OMEGA SPECIAL ELEKTROLYTFRI
●
if you are allergic to any of the active substances, to egg, peanut,
soybean or fish or to any of the other
ingredients of this medicine (listed in section 6).
●
This medicine must not be given to newborn infants, infants and
toddlers under two years old.
A
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                PRODUKTRESUMÉ
1.
LÄKEMEDLETS NAMN
Nutriflex Omega 56/144/40 elektrolytfri, infusionsvätska, emulsion
2.
KVALITATIV OCH KVANTITATIV SAMMANSÄTTNING
Den bruksfärdiga infusionsvätskan innehåller, efter blandning av
kamrarna:
_FRÅN DEN ÖVERSTA KAMMAREN_
_(GLUKOSLÖSNING)_
I 1 000 ML
I 625 ML
I 1 250 ML
I 1 875 ML
Glukosmonohydrat
158,4 g
99,00 g
198,0 g
297,0 g
motsvarande glukos
144,0 g
90,00 g
180,0 g
270,0 g
_FRÅN DEN MELLERSTA KAMMAREN_
_(FETTEMULSION)_
I 1 000 ML
I 625 ML
I 1 250 ML
I 1 875 ML
Medellångkedjiga triglycerider
20,00 g
12,50 g
25,00 g
37,50 g
Sojaolja, raffinerad
16,00 g
10,00 g
20,00 g
30,00 g
Omega-3-syratriglycerider
4,000 g
2,500 g
5,000 g
7,500 g
_FRÅN DEN NEDERSTA KAMMAREN_
_(AMINOSYRALÖSNING)_
I 1 000 ML
I 625 ML
I 1 250 ML
I 1 875 ML
Isoleucin
3,284 g
2,053 g
4,105 g
6,158 g
Leucin
4,384 g
2,740 g
5,480 g
8,220 g
Lysinmonohydrat
3,576 g
2,235 g
4,470 g
6,705 g
motsvarande lysin
3,184 g
1,990 g
3,979 g
5,969 g
Metionin
2,736 g
1,710 g
3,420 g
5,130 g
Fenylalanin
4,916 g
3,073 g
6,145 g
9,218 g
Treonin
2,540 g
1,588 g
3,175 g
4,763 g
Tryptofan
0,800 g
0,500 g
1,000 g
1,500 g
Valin
3,604 g
2,253 g
4,505 g
6,758 g
Arginin
3,780 g
2,363 g
4,725 g
7,088 g
Histidin
1,752 g
1,095 g
2,190 g
3,285 g
Alanin
6,792 g
4,245 g
8,490 g
12,73 g
Asparaginsyra
2,100 g
1,313 g
2,625 g
3,938 g
Glutaminsyra
4,908 g
3,068 g
6,135 g
9,203 g
Glycin
2,312 g
1,445 g
2,890 g
4,335 g
Prolin
4,760 g
2,975 g
5,950 g
8,925 g
Serin
4,200 g
2,625 g
5,250 g
7,875 g
I 1 000 ML
I 625 ML
I 1 250 ML
I 1 875 ML
Aminosyrainnehåll [g]
56,0
35,0
70,1
105,1
Kväveinnehåll [g]
8
5
10
15
Kolhydratinnehåll [g]
144
90
180
270
Lipidinnehåll [g]
40
25
50
75
Hjälpämne(n) med känd effekt:
Natrium (från natriumoleat och natriumhydroxid) max. 0,5 mmol/l i
bruksfärdig emulsion.
För fullständig förteckning över hjälpämnen, se avsnitt 6.1.
3.
LÄKEMEDELSFORM
Infusionsvätska, emulsion
Aminosyra- och glukoslösningar: klara, färglösa till halmfärgade
lösningar
Fettemulsion: olja-i-vatten-emulsion, mjölkvit
I 1 000 ML
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 영어 07-05-2021
제품 특성 요약 제품 특성 요약 영어 29-11-2017
공공 평가 보고서 공공 평가 보고서 영어 12-12-2016